004310.KS
Hyundai Pharmaceutical Co., Ltd.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 7,680.00
+1.45%Margins
Gross margin
35.8%
EBITDA margin
5.7%
EBIT margin
3.0%
Net margin
2.2%
FCF margin
-0.1%
3.5%
Return on equity
2.0%
Return on assets
3.4%
Return on invested capital
0.90x
Asset turnover
KRW 3.2B
Cash from operations
KRW 714
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of May 1, 2026